255 related articles for article (PubMed ID: 30868743)
1. First description of an IgM monoclonal antibody causing α
Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
[TBL] [Abstract][Full Text] [Related]
2. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
[TBL] [Abstract][Full Text] [Related]
3. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
[TBL] [Abstract][Full Text] [Related]
4. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
[TBL] [Abstract][Full Text] [Related]
5. A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin alpha(IIb)beta3.
Tomiyama Y; Shiraga M; Kinoshita S; Ambo H; Kurata Y; Matsuzawa Y; Kunicki TJ
Thromb Haemost; 1998 Nov; 80(5):735-42. PubMed ID: 9843164
[TBL] [Abstract][Full Text] [Related]
6. In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
Pillois X; Peters P; Segers K; Nurden AT
Mol Genet Genomic Med; 2018 Mar; 6(2):249-260. PubMed ID: 29385657
[TBL] [Abstract][Full Text] [Related]
7. Anti-α
Fiore M; d'Oiron R; Pillois X; Alessi MC
Br J Haematol; 2018 Apr; 181(2):173-182. PubMed ID: 29611179
[TBL] [Abstract][Full Text] [Related]
8. An α
Kuo YJ; Chen YR; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2017 Nov; 15(11):2230-2244. PubMed ID: 28815933
[TBL] [Abstract][Full Text] [Related]
9. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
[TBL] [Abstract][Full Text] [Related]
10. Acquired Glanzmann thrombasthenia associated with platelet desialylation.
Zheng SS; Perdomo JS; Leung HHL; Yan F; Chong BH
J Thromb Haemost; 2020 Mar; 18(3):714-721. PubMed ID: 31869497
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia.
Bury L; Falcinelli E; Chiasserini D; Springer TA; Italiano JE; Gresele P
Haematologica; 2016 Jan; 101(1):46-56. PubMed ID: 26452979
[TBL] [Abstract][Full Text] [Related]
12. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
Afrasiabi A; Gelain F; Artoni A; Mannucci PM
Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
[TBL] [Abstract][Full Text] [Related]
13. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
Nelson EJ; Nair SC; Peretz H; Coller BS; Seligsohn U; Chandy M; Srivastava A
J Thromb Haemost; 2006 Aug; 4(8):1730-7. PubMed ID: 16879215
[TBL] [Abstract][Full Text] [Related]
14. Immunization against α
Fiore M; Bayat B; Phuangtham R; Blouin L; Huguenin Y; Bein G; Santoso S
J Thromb Haemost; 2021 Jan; 19(1):255-261. PubMed ID: 33090654
[TBL] [Abstract][Full Text] [Related]
15. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
[TBL] [Abstract][Full Text] [Related]
17. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
[TBL] [Abstract][Full Text] [Related]
18. A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.
Honda S; Tomiyama Y; Shiraga M; Tadokoro S; Takamatsu J; Saito H; Kurata Y; Matsuzawa Y
J Clin Invest; 1998 Sep; 102(6):1183-92. PubMed ID: 9739052
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.
Fang J; Hodivala-Dilke K; Johnson BD; Du LM; Hynes RO; White GC; Wilcox DA
Blood; 2005 Oct; 106(8):2671-9. PubMed ID: 15972454
[TBL] [Abstract][Full Text] [Related]
20. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]